Status:
COMPLETED
De-Medicalizing Mifepristone Medical Abortion
Lead Sponsor:
Gynuity Health Projects
Collaborating Sponsors:
Planned Parenthood Federation of America
David and Lucile Packard Foundation
Conditions:
Medical Abortion
Eligibility:
FEMALE
Brief Summary
This study will investigate the possibility that medical abortion using mifepristone and misoprostol - a safe, proven therapy for terminating early first trimester pregnancy - can be administered in a...
Detailed Description
Mifepristone medical abortion has been available in France for a decade and a half and in the United States since 2001. Over this time, it has been demonstrated to be as safe as or safer than either s...
Eligibility Criteria
Inclusion
- Women presenting at study clinics for medical abortion who agree to complete home study card and return for follow-up visit
Exclusion
- Women presenting at study clinics for medical abortion who do not agree to participate in study.
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
End Date :
April 1 2007
Estimated Enrollment :
4410 Patients enrolled
Trial Details
Trial ID
NCT00120224
Start Date
May 1 2005
End Date
April 1 2007
Last Update
April 27 2007
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Planned Parenthood of San Diego and Riverside Counties
San Diego, California, United States, 92108
2
Family Planning Associates Medical Group
Chicago, Illinois, United States, 60630
3
Planned Parenthood of New York City
New York, New York, United States, 10012